Bausch Health Co. Inc. (BHC) Tops Q2 EPS by 36c
Bausch Health Co. Inc. (NYSE: BHC) reported Q2 EPS of $0.40, $0.36 better than the analyst estimate of $0.04. Revenue for the quarter came in at $2.53 billion versus the consensus estimate of $2.48 billion.
For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.
